This review article analyses the existing research on the prolonged use of proton pump inhibitors (PPIs) to diabetic patients. The article summarises the findings of previous studies that have examined the effects of PPIs on glycemic control, cardiovascular outcomes, and other complications associated with diabetes. The review also evaluates the advantages and drawbacks of long-term PPI apply in this patient population. Overall, the evidence suggests that there is no clear consensus regarding the effect of PPIs on glycemic control, cardiovascular outcomes, or other diabetic complications. While some studies suggests persistent PPI usage may be connected with improved glycemic control and reduced cardiovascular risk, these results are not consistent. Additional research is required to further evaluate the potential advantages and hazards of PPI usage in individuals with diabetes.

Proton Pump Inhibitors, Diabetes, Glycemic Control, Cardiovascular Outcomes, Complications